$30.03
-0.58-1.89%
Last update: Nov 10, 7:33 PM
Vera Therapeutics Inc
VERANASDAQ
The average analyst price target for Vera Therapeutics is $66.44, 121.2% above the current price. Of 14 analysts, 12 rate it Buy and 2 Hold. Targets range from $25 to $100. The latest change came on Nov 6, 2026, when Wedbush lowered its price target on Vera Therapeutics from $34 to $29 and kept a Neutral rating.
Price Target Range — 13 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months
